Literature DB >> 17968715

A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells.

Iqbal Massodi1, Drazen Raucher.   

Abstract

The thermally responsive elastin-like polypeptide (ELP) has great potential as a macromolecular drug delivery vehicle due to its ability to be actively targeted to solid tumors by application of focused hyperthermia. Since, the toxicity properties of a new therapeutic delivery vehicle are crucial to its utility as an effective delivery vehicle, we evaluated the cytotoxicity of a thermally responsive Tat-ELP1 in various cell lines in response to hyperthermia. We report that Tat-ELP1 was not cytotoxic at 37 degrees C in SK-MEL-2, SKOV-3 and WI-38 cells, and only mildly toxic in the MCF-7 breast carcinoma cell line. Application of hyperthermia (42 degrees C) in combination with Tat-ELP1 resulted in cytotoxicity in all cell lines tested, and this toxicity was most prominent in the MCF-7 cell line, which was chosen to study the mechanism behind this increased toxicity. We found that Tat-ELP1 combined with hyperthermia caused membrane leakage and apoptosis, resulting in cell death, but no hemolytic effect was observed on murine erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968715     DOI: 10.1080/10611860701502780

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  14 in total

1.  Corneal Penetrating Elastin-Like Polypeptide Carriers.

Authors:  Eric M George; Fakhri Mahdi; Omar C Logue; Grant G Robinson; Gene L Bidwell
Journal:  J Ocul Pharmacol Ther       Date:  2015-12-16       Impact factor: 2.671

2.  Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.

Authors:  Shama Moktan; Eddie Perkins; Felix Kratz; Drazen Raucher
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

3.  A kidney-selective biopolymer for targeted drug delivery.

Authors:  Gene L Bidwell; Fakhri Mahdi; Qingmei Shao; Omar C Logue; Jamarius P Waller; Caleb Reese; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

4.  A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.

Authors:  Gene L Bidwell; Eddie Perkins; Drazen Raucher
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

5.  Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines.

Authors:  Ana-Matea Mikecin; Leslie R Walker; Marija Kuna; Drazen Raucher
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

6.  Elastin-like polypeptides as a purification tag for recombinant proteins.

Authors:  Wafa Hassouneh; Trine Christensen; Ashutosh Chilkoti
Journal:  Curr Protoc Protein Sci       Date:  2010-08

7.  Nanotoxicology of an Elastin-like Polypeptide Rapamycin Formulation for Breast Cancer.

Authors:  Santosh Peddi; S Kenny Roberts; John Andrew MacKay
Journal:  Biomacromolecules       Date:  2020-02-06       Impact factor: 6.988

8.  Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.

Authors:  Iqbal Massodi; Shama Moktan; Aruna Rawat; Gene L Bidwell; Drazen Raucher
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

Review 9.  Applications of elastin-like polypeptides in drug delivery.

Authors:  Sarah R MacEwan; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

10.  Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP.

Authors:  Iqbal Massodi; Gene L Bidwell; Aisha Davis; Abby Tausend; Kimberly Credit; Michael Flessner; Drazen Raucher
Journal:  Clin Exp Metastasis       Date:  2009-01-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.